chloroquine has been researched along with Addison Disease and Cerebral Sclerosis in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raas, Q | 1 |
| van de Beek, MC | 1 |
| Forss-Petter, S | 1 |
| Dijkstra, IM | 1 |
| Deschiffart, A | 1 |
| Freshner, BC | 1 |
| Stevenson, TJ | 1 |
| Jaspers, YR | 1 |
| Nagtzaam, L | 1 |
| Wanders, RJ | 1 |
| van Weeghel, M | 1 |
| Engelen-Lee, JY | 1 |
| Engelen, M | 1 |
| Eichler, F | 1 |
| Berger, J | 1 |
| Bonkowsky, JL | 1 |
| Kemp, S | 1 |
1 other study available for chloroquine and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; Cell Line; C | 2021 |